InvestorsObserver
×
News Home

Is Allscripts Healthcare Solutions Inc (MDRX) Stock Over or Undervalued?

Wednesday, December 07, 2022 11:14 AM | InvestorsObserver Analysts
Is Allscripts Healthcare Solutions Inc (MDRX) Stock Over or Undervalued?

InvestorsObserver gives Allscripts Healthcare Solutions Inc (MDRX) a strong valuation score of 61 from its analysis. The proprietary scoring system considers the underlying health of a company by analyzing its stock price, earnings, and growth rate. MDRX currently holds a better value than 61% of stocks based on these metrics. Long term investors focused on buying-and-holding should find the valuation ranking system most relevant when making investment decisions.

Valuation Rank - 61
MDRX gets a 61 Valuation Rank today. Find out what this means to you and get the rest of the rankings on MDRX!

Metrics Analysis

MDRX has a trailing twelve month Price to Earnings (PE) ratio of 50.5. The historical average of roughly 15 shows a poor value for MDRX stock as investors are paying higher share prices relative to the company's earnings. MDRX's high trailing PE ratio shows that the firm has been trading above its fair market value recently. Its trailing 12-month earnings per share (EPS) of 0.37 does not justify the stock's current price. However, trailing PE ratios do not factor in the company's projected growth rate, resulting in many newer firms having high PE ratios due to high growth potential enticing investors despite inadequate earnings.
MDRX's 12-month-forward PE to Growth (PEG) ratio of 1.8 is considered a poor value as the market is overvaluing MDRX in relation to the company's projected earnings growth due. MDRX's PEG comes from its forward price to earnings ratio being divided by its growth rate. A PEG ratio of 1 represents a perfect correlation between earnings growth and share price. Due to their incorporation of more fundamentals of a company's overall health and focusing on the future rather than the past, PEG ratios are one of the most used valuation metrics by analysts today.

Summary

MDRX' has a weak valuation at its current share price on account of a overvalued PEG ratio despite strong growth. MDRX's PE and PEG are worse than the market average leading to a below average valuation score. Click Here to get the full Report on Allscripts Healthcare Solutions Inc (MDRX) stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App